Search results
Results from the WOW.Com Content Network
In October 2010 the US FDA approved dabigatran etexilate for the prevention of stroke in patients with atrial fibrillation (AF). [ 6 ] [ 10 ] Many pharmaceutical companies have attempted to develop orally bioavailable DTI drugs but dabigatran etexilate is the only one to reach the market.
Dabigatran, sold under the brand name Pradaxa among others, is an anticoagulant used to treat and prevent blood clots and to prevent stroke in people with atrial fibrillation. [ 6 ] [ 7 ] Specifically it is used to prevent blood clots following hip or knee replacement and in those with a history of prior clots. [ 6 ]
Factors considered before deciding on whether warfarin or a DOAC or which direct factor Xa inhibitor is used, include: the presence or absence of valvular heart disease, state of kidney function, the risk of stroke and the risk of bleeding. [8]
After Stark County reported its sixth consecutive increase in overdose deaths in 2023, local health officials say 2024 appears promising. Drug overdose deaths down in Ohio, but increase in Stark ...
The Ohio Department of Health’s annual Unintentional Drug Overdose Report showed a 9% decline in verified overdose deaths across the state. In 2023, there were 4,452 unintentional drug overdose ...
Overdose deaths in Ohio fell to an eight-year low in January. Experts disagree on why, but the answer could help save lives in the future. Overdose deaths in Ohio reached an 8-year low.
We undertook a post-hoc analysis of data from the ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation, n = 14,624) for stroke or non-CNS embolism within 30 days after temporary interruptions of 3 days or more, early permanent ...
Fewer Ohioans are dying of drug overdoses because of better access to naloxone, opioid treatment and peer support, Gov. Mike DeWine said Wednesday.